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Abstract
RACK1 is a scaffolding protein that contributes to the specificity and propagation of several
signaling cascades including the cAMP pathway. As such, RACK1 participates in numerous
cellular functions ranging from cell migration and morphology to gene transcription. To
obtain further insights on the mechanisms whereby RACK1 regulates cAMP-dependent
processes, we set out to identify new binding partners of RACK1 during activation of the
cAMP signaling using a proteomics strategy. We identified β-actin as a direct RACK1 bind-
ing partner and found that the association between β-actin and RACK1 is increased in
response to the activation of the cAMP pathway. Furthermore, we show that cAMP-depen-
dent increase in BDNF expression requires filamentous actin. We further report that β-actin
associates with the BDNF promoter IV upon the activation of the cAMP pathway and pres-
ent data to suggest that the association of β-actin with BDNF promoter IV is RACK1-depen-
dent. Taken together, our data suggest that β-actin is a new RACK1 binding partner and
that the RACK1 and β-actin association participate in the cAMP-dependent regulation of
BDNF transcription.
Introduction
RACK1 is a ubiquitous scaffolding protein that belongs to the tryptophan-aspartate (WD-40)
repeat family of proteins [1, 2]. A critical feature of RACK1 is its multifaceted and compact
propeller structure, which allows the protein to associate with several binding partners at the
same time [1, 2], and this characteristic makes RACK1 a unique molecular node with the
capacity for integrating and converting several signals into a cellular response.
RACK1 was originally identified as a βII protein kinase C (βII PKC) binding protein that
targets the active kinase to its proper subcellular location [3]. Through its association with
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numerous other signaling molecules, RACK1 was later found to participate in the propagation
and accuracy of other major cascades including the cAMP signaling pathway [1, 2]. For exam-
ple, RACK1 binds the cAMP-specific degrading hydrolase, phosphodiesterase 4D5 (PDE4D5)
[4], and provides a focal point for the cross-talk between the PKC and cAMP signaling cascades
[5]. In addition, RACK1 facilitates the transcription of genes via a cAMP-dependent transloca-
tion of the scaffolding protein to the nucleus [6–9]. Specifically, activation of cAMP signaling
leads to the sequestration of RACK1 in the nucleus where the scaffolding protein associates
with the brain-derived neurotrophic factor (BDNF) promoter IV, resulting in epigenetic-depen-
dent increase in the transcription of the neurotrophic factor [6].
As RACK1 signals by means of protein-protein association, deciphering its interaction net-
work in response to an activation of specific signaling cascades is a critical step towards under-
standing the cellular processes that are regulated by the scaffolding protein.
Here, we set out to identify cAMP-responsive binding partners of RACK1. We found that
RACK1 directly interacts with β-actin and that the association between the two proteins is
increased upon activation of cAMP signaling. Importantly, our data also suggest that a func-
tional interplay between RACK1 and nuclear β-actin regulates cAMP-induced BDNF
transcription.
Material and Methods
Materials
Anti-RACK1 (sc-17754), anti-pan actin (sc-1616), anti-GAPDH (sc-25778) antibodies and the
horseradish peroxidase (HRP)-conjugated secondary antibodies were purchased from Santa
Cruz Biotechnology. Anti-phospho-CREB (#9191), and anti-CREB (#9121) antibodies were
from Cell Signaling. Anti-β-actin antibody (#A5316, clone AC-74), forskolin, (FSK) cytochala-
sin D and phosphatase inhibitor cocktails 1 and 2 were purchased from Sigma-Aldrich. The
protease inhibitor mixture was purchased from Roche Applied Science. Nuclear proteins were
isolated using the NE-PER Nuclear and Cytoplasmic Extraction Reagents from Thermo Scien-
tific. Trypsin, and the reverse transcription system and 2X PCR Master Mix were purchased
from Promega and SYBR1 Green PCRMaster Mix was from Applied Biosystem. Primers for
PCR were synthesized by Sigma-Genosys. Chromatin immunoprecipitation (ChIP) assay kit
was fromMillipore. Amylose resin was from New England BioLabs. Deep Purple™ Total Pro-
tein Stain and Enhanced Chemiluminescence (ECL) were from GE Healthcare. Non-muscle
purified actin>99% purity (#APHL99) was purchased from Cytoskeleton. NuPAGE1 Bis-
Tris pre-casted gels and recombinant protein G-agarose were from Invitrogen.
Cell culture
SH-SY5Y human neuroblastoma cells were cultured in Dulbecco’s modified Eagle medium
(DMEM) containing 10% fetal bovine serum (FBS) supplemented with non-essential amino
acid solution. Cells were incubated in a low-serum medium containing 1% FBS for at least 24 h
before treatment.
RACK1 immunoprecipitation and gel staining
For RACK1 immunoprecipitation from total cell extract, SH-SY5Y cells were lysed in immuno-
precipitation (IP) buffer (1% Triton X-100, 150 mMNaCl, 10 mM Tris HCl, pH 7.4, 1 mM
EDTA, 1 mM EGTA, and protease and phosphatase inhibitor cocktails).
For RACK1 immunoprecipitation from nuclear extract, SH-SY5Y were rinsed twice with
ice-cold phosphate buffered saline and spun down for 1 min at 500 g. Nuclear proteins were
RACK1/β-Actin and BDNF Transcription
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isolated using the NE-PER Nuclear and Cytoplasmic Extraction Reagents according to the pro-
vider’s instructions, then diluted in IP buffer.
Nuclear or total cell extract diluted in IP buffer was pre-cleared and incubated with anti-
RACK1 antibody or IgG. After overnight incubation at 4°C, recombinant protein G-agarose
was added, and the mixture was further incubated at 4°C for 2 h. The agarose resin was exten-
sively washed with IP buffer, the immunoprecipitated proteins were eluted in loading buffer
(2% SDS, 23% β-mercaptoethanol, 50 mM Tris HCl, pH 6.8, 10% glycerol, 1 mm EDTA, 0.1%
bromophenol blue), and resolved by SDS-PAGE. Gels were stained with Deep Purple™ Total
Protein Stain according to the provider’s instructions and scanned with Typhoon™ scanner
(GE Healthcare) (excitation 532 nm, emission 610BP filter).
Mass spectrometry identification of proteins
Identification of proteins for RACK1 IP from total cell extract was conducted as previously
described [9]. Briefly, whole lanes of interest (IgG versus RACK1) were manually excised and
cut into small pieces from a representative gel. Identification of proteins for RACK1 IP from
nuclear extract was conducted on the gel slice of interest. Proteins were subjected to trypsin
digestion and mixtures of proteolytic peptides were on-line separated by nanoLC utilizing the
Eksigent 2D LC NanoLC System (Eksigent/AB Sciex) interfaced with the QStar XL mass spec-
trometer (Applied Biosystems Sciex). ProteinPilot™ Software 4.0, which utilizes the Paragon™
Algorithm (Applied Biosystems Sciex), was used for peak detection, mass peak list generation
and database searches. Protein identifications based on multiple peptides were accepted using a
cut-off score of 1.69897 that represented more than 98% confidence.
Western blot analysis
Proteins were resolved on a 4%-12% SDS-PAGE gel and were transferred onto nitrocellulose
membranes. Membranes were blocked for 1 h with 5% (w/v) nonfat milk in Tris Buffered
Saline containing 0.1% (v/v) Tween 20 (TBS-T), then incubated overnight at 4°C in the block-
ing solution including the appropriate antibody. After extensive washes with TBS-T, bound
primary antibodies were detected with HRP-conjugated secondary antibodies and visualized
by ECL.
MBP Column Assay
MBP and MBP-RACK1 constructs were previously described [10]. Recombinant proteins were
expressed in Escherichia coli by the induction with 1.5 mM isopropyl β-D-1-thiogalactopyrano-
side (IPTG) for 4 h. Cells were then lysed by successive freeze/thaw cycles and sonication.
Crude extracts of MBP-fusion proteins were incubated with 1 ml pre-washed amylose suspen-
sion, and the column was washed extensively with column buffer (20 mm Tris-HCl, pH 7.5,
200 mm NaCl, 1 mm EDTA, 0.002% sodium azide, and 10 mm β-mercaptoethanol). SH-SY5Y
lysate (1 mg), diluted to 1 μg/μl in IP buffer, was applied to the column for 1 h at room temper-
ature. After washes with 30 ml of a solution containing 50 mm Tris-HCl, pH 7.5, 0.1% polyeth-
ylene glycol (Mr 15000–20000), 1.2 mm β-mercaptoethanol and 0.2 m NaCl, bound proteins
were eluted 3 times with 500 μl of column buffer supplemented with 50 mmmaltose and
resolved by SDS-PAGE. Proteins were stained with colloidal Coomassie blue (G-250) or further
analyzed by western blot.
For actin binding assay, 25 μg of>99% purified non-muscle actin (a mix of 85% and 15% of
β-actin and γ-actin respectively according to the provider) diluted in 1 ml of IP buffer was
applied to purified MBP or MBP-RACK1 immobilized on amylose resin. After 2 h incubation
RACK1/β-Actin and BDNF Transcription
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at room temperature, amylose resin was washed as described above. Bound proteins were
eluted with loading buffer or 50 mmmaltose and analyzed by western blot.
Reverse transcription and semi-quantitative polymerase chain reaction
(RT-PCR)
Total RNA was isolated using TRIzol reagent and 1 μg was reverse transcribed via the reverse
transcription system, with incubation at 42°C for 30 min followed by 6 min at 95°C. Gene
expression was analyzed by semi-quantitative PCR with temperature cycling parameters con-
sisting of initial denaturation at 94°C for 2 min followed by cycles of denaturation at 94°C for
30 s, annealing at 58°C for 30 s, extension at 72°C for 2 min, and a final incubation at 72°C for
7 min. PCR products were resolved on a 1.8% agarose gel in Tris/acetic acid/EDTA buffer with
0.25 μg/ml ethidium bromide and photographed by Eagle Eye II (Stratagen, La Jolla, CA). The
images were digitally scanned and the signals were quantified by densitometry using the NIH
Image 1.63 program. The following primers were used for the PCR analysis: BDNF-Forward
5’-CTT TGG TTG CAT GAA GGC TGC-3’, BDNF-Reverse 5’-GTC TAT CCT TAT GAA
TCG CCA G-3’, GAPDH-Forward 5’-TGA AGG TCG GTG TGA ACG GAT TTG GC-3’ and
GAPDH-Reverse 5’- CAT GTA GGC CAT GAG GTC CAC CAC-3’.
Semi-quantitative PCR analysis of the chromatin immunoprecipitation (ChIP) samples was
conducted using the following BDNF PIV primers: forward 5’-AAG CAT GCA ATG CCC
TGG AAC-3’ and reverse 5’-TGC CTT GAC GTG CGC TGT CAT-3’. Products of ChIP-PCR
were separated on a 2% agarose gel with ethidium bromide, and the PCR signals were quanti-
fied using NIH Image 1.63.
Quantitative PCR (qPCR)
qPCR of ChIP samples was performed in an Applied Biosystems 7900 real-time PCR unit
using SYBR1 Green PCRMaster Mix following manufacturer’s instructions. Each indepen-
dent sample was assayed in triplicate. The primer sequences used in the ChIP-qPCR assays are:
BDNF PIV: forward 5’-CCC TGG AAC GGA ACT CTT CTA AT-3’ and reverse 5’-CCG CTG
CCT CGA AAT AGA C-3’.
Chromatin immunoprecipitation (ChIP) assay
ChIP was conducted using the Millipore ChIP assay kit following the manufacturer’s protocol.
Briefly, cells were cross-linked with 1% paraformaldehyde and lysed in 1% SDS containing
buffer. After gentle sonication, protein concentration was determined by BCA assay and the
same amount of cross-linked chromatin was incubated with 5 μg of anti-β-actin (clone AC-74)
antibody, which was previously used for this application [11]. DNA-β-actin complex was
immunoprecipitated with recombinant protein G-agarose, reverse cross-linked and DNA was
extracted by ethanol precipitation. DNA from ChIP samples was then analyzed by semi-quan-
titative or quantitative PCR (qPCR).
Cloning and Preparation of Recombinant Adenoviruses
The preparation of the shRACK1 recombinant adenoviruses was previously described [6]. The
shRACK1 sequence GAC CAT CAT CAT GTG GAA GC used to knockdown RACK1 was pre-
viously validated in SH-SY5Y cells [6]. A recombinant adenovirus expressing the non-related
19-nt sequence (shCT), ATG AAC GTG AAT TGC TCA A, was used as control [6]. Viruses
were amplified in HEK293 cells, then purified using the Adeno-XTM Maxi Purification kit, and
tittered with the Adeno-X Rapid Titer kit (Clontech). SH-SY5Y cells were infected with the
RACK1/β-Actin and BDNF Transcription
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virus 3 days before CHIP assay. Viruses were used at a concentration of 1 × 106 infection units/
ml.
Data analysis
Depending of the design of the experiment, data were analyzed with one-way ANOVA or two-
way ANOVA. Significant main effects and interactions of the ANOVAs were further investi-
gated with the Newman-Keuls post hoc test or with two-tailed unpaired t-test. Statistical signif-
icance was set at p< 0.05. Data are presented as mean ± SEM.
Results
Mass spectrometry identification of actin as a RACK1 binding partner
We aimed at identifying proteins that interact with RACK1 interactions that occurr specifically
in response to the activation of the cAMP signaling. To do so, we used the neuroblastoma
SH-SY5Y cells as a cell model system and utilized “interactomics” approach in which RACK1
was immunoprecipitated (IPed) following activation of cAMP signaling by the adenylate
cyclase activator, forskolin (FSK). Proteins that co-immunoprecipitated (co-IPed) with
RACK1 were resolved by SDS-PAGE (Fig 1A) and submitted to mass spectrometry (MS) for
identification. To rule out possible non-specific interactions, proteins recovered from the IgG
control gel were also analyzed by MS. This strategy led to the identification of 5 different actin
isoforms which we found to be enriched in the RACK1 IP lane as compared to the correspond-
ing IgG control lane as shown by the higher number of identified peptides (Fig 1B). Among
these actin isoforms, actin cytoplasmic 1 (β-actin) and actin cytoplasmic 2 (γ-actin) had the
highest identification score than the 3 other actin isoforms (25.7 versus 11.2; Fig 1B). Due to
the high protein sequence homology between β-actin and γ-actin isoforms (more than 98%
identity due to only four amino acids substitutions within the N-terminus), only one peptide
out of 13 allowed for discrimination between the β and γ isoforms. Together, these data raise
the possibility that actin and particularly β/γ-actin binds to RACK1.
RACK1 and β-actin are direct binding partners
We focused our studies on the β-actin isoform, and first confirmed that β-actin is indeed a
RACK1 binding partner by using several complementary biochemical methods. First,
SH-SY5Y cells were treated with FSK for 30 min, RACK1 was IPed from whole cell lysate, and
the presence of β-actin in the RACK1 IP condition was examined by western blot analysis
using an antibody that specifically detects β-actin. As shown in Fig 2A, we observed a specific
interaction between endogenous RACK1 and β-actin in cells that were treated with FSK, vali-
dating the MS data presented in Fig 1. Next, we tested the ability of recombinant RACK1 to
bind β-actin from FSK-activated cells. Specifically, recombinant RACK1 fused to maltose bind-
ing protein (MBP) or MBP was immobilized on an amylose resin column (Fig 2B, left panel).
Equal amounts of cell lysates treated with FSK for 30 min were then applied to both columns,
and the interaction of endogenous β-actin with the eluted MBP-RACK1 or MBP was tested by
western blot analysis. We found that endogenous β-actin bound MBP-RACK1 but not MBP
(Fig 2B, right upper panel). As an additional control, we also examined whether endogenous
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was also eluted with the recombinant
proteins and found that GAPDH did not interact with either MBP or MBP-RACK1 (Fig 2B
right lower panel). Together, these data demonstrate that the association of RACK1 and β-
actin is specific.
RACK1/β-Actin and BDNF Transcription
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Next, we determined whether the interaction between RACK1 and β-actin was direct. To
test this possibility, we carried out an in vitro binding assay in which the association between
purified RACK1 and β-actin was examined. Recombinant MBP-RACK1 or MBP were immobi-
lized on an amylose resin column and then incubated with purified non-muscle actin, which is
composed of 85% and 15% β-actin and γ-actin respectively. Using pan-anti-actin antibodies,
we observed that actin was specifically eluted with MBP-RACK1 but not MBP (Fig 2C). These
data indicate that the association between RACK1 and β-actin is mediated through a direct
protein-protein interaction.
Fig 1. Mass spectrometry identification of actin as a binding partner of RACK1. A SH-SY5Y cells were treated with 10 μMFSK for 30 min, RACK1
was IPed from cell lysate and proteins were resolved by SDS-PAGE which was stained with Deep Purple™ to visualize proteins. Gel slices from both
RACK1 and control IgG IPs were digested in-gel and the resulting peptides were submitted to tandemmass spectrometry (MS/MS) sequencing for
protein identification, n = 2. B Identification of actin as a putative RACK1 binding protein. β-actin (ACTB), γ-actin (ACTG), alpha skeletal muscle actin
(ACTS), aortic smooth muscle actin (ACTA), alpha cardiac muscle actin (ACTC) were identified in the RACK1 IP. A sum of score of peptides that were
matched to the best hit within the family of homologous protein sequences (1). Calculation of the percent sequence coverage included all peptides
matched to the protein, i.e., both unique and common peptides (2). Differentiation between ACTC, ACTS and ACTA proteins was not possible on the
basis of the data since the identified peptides were common to all of them (3). Differentiation between β-actin and γ-actin proteins was not possible on
the basis of the data since the identified peptides were common to both isoforms (4).
doi:10.1371/journal.pone.0160948.g001
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Fig 2. β-actin is a direct binding partner of RACK1. A SH-SY5Y cells were treated with 10 μMFSK for 30 min, and were then lysed in IP buffer. RACK1
was IPed from whole cell lysate and the co-IPed proteins were resolved by SDS-PAGE. Endogenous RACK1 and β-actin were analyzed by western blot
analysis. B Recombinant MBP and MBP-RACK1 were immobilized on an amylose resin column and incubated with SH-SY5Y lysate previously treated
with 10 μM FSK for 30 min. After washing, bound proteins were eluted 3 times with 50 mMmaltose (E1, E2 and E3) or with loading buffer (MBP and
RACK1/β-Actin and BDNF Transcription
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To test whether RACK1 preferentially binds monomeric G-Actin or filamentous F-Actin,
RACK1 was IPed from SH-SY5Y cells that were previously treated with 1 μM of cytochalasin
D, a drug that induces the depolymerization of F-actin into G-actin [12]. We observed that
treatment of cells with cytochalasin D did not alter the ability of β-actin to co-IP endogenous
RACK1 (Fig 2D). These data indicate that in non-stimulated conditions, the association
between RACK1/β-actin relies on the interaction of RACK1 with monomeric G-actin.
Activation of the cAMP pathway increases the association between
RACK1 and β-actin
Next, we examined whether activation of the cAMP pathway regulates the association between
RACK1 and β-actin. To do so, endogenous RACK1 was IPed from SH-SY5Y cells treated with
or without FSK, and the amount of β-actin co-IPed with RACK1 was measured by western blot
analysis. As shown in Fig 3, we found that RACK1 and β-actin interacts both in the presence
and absence of FSK stimulus. However, the activation of the cAMP pathway leads to a signifi-
cant increase in β-actin interaction with RACK1 (Fig 3).
Disruption of actin filament inhibits cAMP-mediated BDNF transcription
Activation of the cAMP pathway results in the regulation of several cellular functions including
modification of cytoskeletal dynamics in the cytosol [13] and activation of gene transcription
in the nucleus [6–8, 14, 15], and RACK1 has been shown to play a central role in these pro-
cesses [6, 9, 16]. We previously reported that activation of the cAMP pathway results in
RACK1-dependent BDNF transcription in SH-SY5Y cells [6]. Therefore, we asked whether β-
actin also plays a role in cAMP-mediated BDNF gene transcription. To address this question,
we first examined whether alterations of actin function affect cAMP-mediated BDNF tran-
scription. To do so, SH-SY5Y cells were treated with cytochalasin D, an inhibitor of actin poly-
merization, prior to activation of the cAMP pathway by FSK, and BDNFmRNA levels were
measured by RT-PCR. As shown in Fig 4A, multiple comparisons analyses using Newman-
Keul’s post hoc test show that following treatment of SH-SY5Y cells with cytochalasin D, acti-
vation of the cAMP cascade by FSK was unable to robustly promote BDNF transcription (see
histogram in Fig 4A). Noteworthy, we obtained the same conclusion using Tukey, Holm-Sidak
and Fisher’s LSD post hoc tests (data not shown). These data suggest that disruption of actin
filaments using cytochalasin D attenuates cAMP-mediated induction of BDNF transcription.
To test whether cytochalasin D-mediated function was specific to BDNF transcription and
was not due to a mere and global blockade of cAMP signaling, we examined phosphorylation
level of the cAMP response element binding protein (CREB), a well-described substrate of pro-
tein kinase A [17], in response to FSK treatment with vehicle or cytochalasin D. We observed
that disruption of actin filaments with cytochalasin D did not affect cAMP-mediated phos-
phorylation of CREB (Fig 4B). Taken together, these data raised the possibility that actin is
involved in the mechanisms that promote cAMP-mediated BDNF transcription.
MBP-RACK1 beads). Proteins were resolved by SDS-PAGE and the presence of β-actin and GAPDH was determined by western blot (right panel). The
amount of MBP and MBP-RACK1 recovered after elution was also controlled with colloidal coomassie blue staining (left panel). n = 2.C The experiment
was conducted as in panelB except that immobilized recombinant MBP and MBP-RACK1 were incubated with pure non-muscle actin. After washing,
proteins were eluted twice with 50 mMmaltose (E1 and E2) or with loading buffer (bead lanes). Eluted proteins were resolved by SDS-PAGE, transferred
to nitrocellulose membrane and stained with Ponceau S to control the amount of MBP and MBP-RACK1 (upper panel). The presence of actin was
subsequently determined by western blot analysis using a pan actin antibody (lower panel).D SH-SY5Y cells were incubated with vehicle or 1 μM
cytochalasin D (cytoD) for 30 min, and then lysed in IP buffer. RACK1 was immunoprecipitated from whole cell lysate and proteins were resolved by
SDS-PAGE. RACK1 and β-actin were revealed by western blot analysis. Histogram depicts the mean ratio of β-actin to RACK1, expressed as percent
control ± SEM. Two-tailed unpaired t-test, p = 0.40. A n = 3, B and C n = 2, D n = 6.
doi:10.1371/journal.pone.0160948.g002
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RACK1 binds nuclear β-actin
Although actin is primarily known for its cytosolic function as a major component of the
cytoskeleton, actin is also found in the nucleus [18, 19]. In this cell compartment, the
monomeric β-actin isoform has been reported to regulate several stages of gene transcrip-
tion including chromatin remodeling [18, 19]. In addition, β-actin has been shown to bind
the promoters of both housekeeping and inducible genes [11, 20, 21]. We previously
reported that, in response to cAMP pathway activation, RACK1 is present at the BDNF pro-
moter IV, where it is required for chromatin remodeling and subsequent promoter activa-
tion [6]. Hence, we next hypothesized that nuclear β-actin contributes to cAMP-mediated
BDNF transcription. To address this possibility, we first set out to examine whether RACK1
and β-actin interact in the nuclear compartment. To do so, SH-SY5Y cells were treated with
FSK for 30 min, then nuclear proteins were isolated and nuclear RACK1 was IPed. Co-IPed
proteins were resolved by SDS-PAGE and stained with Deep PurpleTM. As shown in Fig 5A,
we observed that a protein, whose molecular weight is similar to actin (around 42 kDa), was
specifically recovered in RACK1 but not in the IgG control lanes. This protein was further
identified as β/γ-actin by MS (Fig 5B), suggesting that RACK1 and actin also interact in the
nuclear compartment.
Fig 3. Activation of the cAMP pathway increases the association between RACK1 and β-actin. A
SH-SY5Y cells were treated with vehicle or 10 μM FSK for the indicated duration, then lysed in IP buffer.
RACK1 was IPed from whole cell lysate and proteins were resolved by SDS-PAGE. The presence of RACK1
and β-actin was determined by western blot analysis.BQuantification of A. Histogram depicts the mean ratio
of β-actin to RACK1, expressed as percent control (0 min) ± SEM. One-way ANOVA showed a significant
effect of treatment [P = 0.002]. *p<0.05, **p<0.01 vs. 0 min, Newman-Keuls post-hoc analysis. n = 3.
doi:10.1371/journal.pone.0160948.g003
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Fig 4. Disruption of actin filaments using cytochalasin D attenuates cAMP-mediatedBDNF
transcription without blocking the phosphorylation of CREB. A SH-SY5Y cells were incubated with
vehicle or 1 μM cytochalasin D for 15 min prior to treatment with 10 μM FSK for 1 h. BDNF andGAPDH
mRNA levels were analyzed by RT-PCR. Histogram depicts the mean ratio of BDNF toGAPDH expressed as
percent control (vehicle) ± SEM. Two-way ANOVA shows an interaction between FSK and cytochalasin D
[P = 0.049]. ***p<0.001, *p<0.05, ns p = 0.177, Newman-Keuls post-hoc analysis.B SH-SY5Y cells were
incubated with vehicle or 1 μM cytochalasin D for 15 min prior to treatment with 10 μM FSK for 30 min, then
lysed in IP buffer. Proteins were resolved by SDS-PAGE and the phosphorylation of CREB on serine 133
was examined by western blot analysis. Histogram depicts the mean ratio of phospho-CREB to total CREB,
expressed as percent control (vehicle) ± SEM. Two-way ANOVA shows an effect of FSK [P < 0.001] but no
effect of cytochalasin D [P = 0.756] and no interaction [P = 0.966]. Subsequent analysis by the method of
RACK1/β-Actin and BDNF Transcription
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β-actin localizes at BDNF promoter IV following activation of the cAMP
pathway in a mechanism that requires RACK1
As the activation of the cAMP pathway promotes RACK1 translocation to the nucleus where it
associates with the BDNF promoter IV enabling subsequent promoter activation [6], we
hypothesized that nuclear β-actin contributes to cAMP-mediated BDNF transcription by its
association with RACK1 at the BDNF IV promoter. To address this possibility, we first exam-
ined whether β-actin was present at the promoter IV of BDNF upon activation of cAMP
contrasts (two-tailed unpaired t-test) detected a significant difference between control and FSK in both
vehicle and cytochalasin D groups. **p = 0.002 and ***p<0.001. A n = 9, B n = 3.
doi:10.1371/journal.pone.0160948.g004
Fig 5. Nuclear association of RACK1 with β-actin. SH-SY5Y cells were treated with 10 μM FSK for 30 min, nuclear proteins were isolated
and nuclear RACK1 was immunoprecipitated. Proteins were resolved by SDS-PAGE and the gel was stained with Deep Purple™ to visualize
proteins. The gel slice indicated by an arrow was in-gel protein digested and resulting peptides were submitted to mass spectrometry (MS/MS)
sequencing for protein identification. B Table shows the data leading to the identification of β-actin (ACTB) and γ-actin (ACTG) proteins.
Numbers refer to the legend of Fig 1B.
doi:10.1371/journal.pone.0160948.g005
RACK1/β-Actin and BDNF Transcription
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signaling. To do so, ChIP-PCR (Fig 6A) and ChIP-qPCR (Fig 6B) assays were performed to
probe the presence of β-actin at BDNF promoter IV following activation of cAMP signaling by
FSK. We observed that treatment of SH-SY5Y cells with FSK led to the binding of β-actin to
BDNF promoter IV (Fig 6A and 6B).
Finally, to test whether RACK1 is required for the association of β-actin with BDNF IV pro-
moter, the RACK1 gene was silenced using a previously validated shRNA sequence [6] and a β-
actin ChIP assay was performed. We found that shRNA-mediated knockdown of RACK1 pre-
vented the binding of β-actin to BDNF promoter IV in response to FSK treatment (Fig 6C).
Together, these results suggest that cAMP-mediated binding of β-actin to BDNF promoter IV
requires RACK1 and implicates β-actin in the mechanisms regulating cAMP-induced BDNF
transcription.
Discussion
In the present study, we report that β-actin is a new direct binding partner of the scaffolding
protein RACK1, and provide evidence to suggest that this interaction is modulated by cAMP
signaling. Our findings also indicate that the interaction between RACK1 and β-actin occurs in
both the cytosolic and nuclear cell compartments. Finally, our data suggest that a functional
interplay between β-actin and RACK1 is key for cAMP-induced BDNF transcription.
β-actin and γ-actin are the major actin isoforms in non-muscle cells [22]. Although several
lines of evidence show that the two isoforms have distinct functions [22, 23], they are 98%
identical and our MS data suggest that RACK1 interacts indistinctly with both isoforms, how-
ever, this possibility needs to be confirmed.
We found that recombinant RACK1 interacts with purified actin in vitro suggesting that the
association between the two proteins is direct. In cells, non-muscle actin exists in two main
functionally and structurally different forms: globular actin (G-actin) and filamentous (F-
actin), which correspond to the monomeric and polymerized cytoskeletal actin, respectively
[24, 25]. The polymerization of G-actin into F-actin is a fine-tuned process that requires impli-
cates the presence of actin binding proteins or actin-related proteins (Arp) such as Arp2/3 or
cofilin [26, 27]. The fact that we found that disruption of F-actin filaments by cytochalasin D
did not affect RACK1/β-actin basal interaction indicates that in non-stimulated conditions,
RACK1 is able to interact with G-actin.
We also show that RACK1/β-actin interaction is enhanced in response to adenylate cyclase
activation. The main mode of transducing adenylate cyclase signal is via the activation of pro-
tein kinase A (PKA), thus, it is plausible that cAMP-mediated RACK1/β-actin interaction relies
on a phosphorylation event, although RACK1 is not a direct substrate of PKA (Ron D., unpub-
lished data). RACK1 subcellular location is sensitive to various stimuli [28, 29] including
cAMP signaling [6, 8, 9], and thus, another possibility is that the activation of the cAMP path-
way triggers the translocation of RACK1 towards actin microfilaments leading to the associa-
tion of the two binding partners within the cytoskeletal structure. In a similar fashion, βIIPKC
and RACK1 associate in response to stimuli prior to their translocation to a specific site [29].
The interaction between RACK1/β-actin raises the interesting possibility that RACK1 plays
a role in the control of cytoskeleton dynamics. Interestingly, cAMP signaling can modulate
cytoskeletal organization, for example by promoting migration and spreading of cells [13] and
by contributing to neurite outgrowth in the nervous system [30]. Interestingly, RACK1 has
been reported to play a role in the translation of β-actin mRNA in neurons [31], and several
studies suggested an indirect involvement of RACK1 in the molecular mechanisms that partici-
pate in actin cytoskeletal dynamics [16, 32, 33], through its capacity to bind Src, PKC or focal
adhesion kinase (FAK), key kinases whose activity controls the dynamics of microfilaments
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Fig 6. Activation of the cAMP pathway increases the association of β-actin with BDNF promoter IV via RACK1. SH-SY5Y cells
were treated with vehicle or with 10 μm FSK for the indicated time points, then lysed for a ChIP assay with normal IgG or anti- β-actin
antibody. The β-actin-associated BDNF promoter IV (PIV) in the ChIP samples was detected by semi quantitative PCR (A) and
quantitative PCR (B). A The level of PIV in the input was analyzed in parallel. The histogram depicts the mean ratio of β-actin -associated
PIV to input PIV expressed as percent control ± SEM. One-way ANOVA detected a significant effect of the treatment [P = 0.020]. *p<0.05
RACK1/β-Actin and BDNF Transcription
PLOS ONE | DOI:10.1371/journal.pone.0160948 August 9, 2016 13 / 17
[34–36]. It is possible that, due to its scaffolding properties, RACK1 binding to the actin cyto-
skeleton brings proteins into close proximity that can then regulate cytoskeletal dynamics.
Alternatively, cAMP-mediated binding of RACK1 to F-actin may competitively displace or
prevent the binding of proteins such as Arp2/3 or cofilin that control the assembly and disas-
sembly of actin filaments [27, 37]. In agreement with this hypothesis, we recently showed that
RACK1 binds 14-3-3z [9], a protein that can regulate cytoskeleton dynamics by interacting
with actin-filament-associated proteins such as cofilin [38]. Thus, our present work paves the
way for the identification of additional roles for RACK1 in this cellular process.
In addition of being a major component of the cytoskeleton, polymeric actin is also present
in the nucleus [39, 40] where it contributes to the dynamics of the nucleoskeleton [41, 42]. Our
data raise the possibility that RACK1 interacts with nuclear β-actin. The possibility that
RACK1 participates in actin nucleoskeleton dynamics is intriguing and merits further investi-
gation. Similar to RACK1 [1], β-actin has reported to be a component of both the chromatin
remodeling complex [43] and the transcriptional machinery [18]. We previously showed that
nuclear RACK1 participates in cAMP-mediated exon IV BDNF expression [6]. In the present
study, we show that like RACK1, β-actin binds promoter IV of BDNF with the same time
course as RACK1 and in both cases the binding of the two proteins with the promoter IV of
BDNF is cAMP-dependent ([6], and herein). Moreover, we observed that cAMP-dependent
binding of β-actin to BDNF promoter IV is abolished when RACK1 gene is silenced. As
RACK1 is required for cAMP-induced exon IV BDNF transcription [6], it is plausible that the
association between RACK1 and β-actin enables the latter to bind to the BDNF promoter IV
promoter, which then recruits histone acetyltransferase, permitting the initiation of transcrip-
tion [18, 21]. The simultaneous binding of RACK1 and β-actin as a protein complex to BDNF
promoter IV is an alternative possibility for the initiation of BDNF exon IV transcription.
Interestingly, we also observed that the association of β-actin with BDNF promoter IV is tran-
sient suggesting that β-actin is released from the promoter following chromatin decondensa-
tion by acetylation of histone H4, which reaches a maximum 30 min after activation of cAMP
signaling [6]. These potential mechanisms that enable RACK1 and β-actin to participate in
exon IV BDNF transcription merit further investigation.
Human BDNF gene structure consists of nine functional promoters that separately control
distinct BDNF exons which are differentially responsive to various stimuli [44]. We previously
showed that although the cAMP pathway participates in the expression of BDNF exon I, IV
and VI, RACK1 plays a specific role in the expression of BDNF exon IV only [6]. Therefore, an
open question that requires further investigation is whether β-actin binds to other BDNF pro-
moters and plays a role in the transcription of other BDNF exons.
Finally, the role of β-actin in gene transcription is not restricted to the stimulation of initia-
tion. β-actin is also thought to be important for transcript elongation and transport [18, 19].
Therefore, the finding that RACK1 and β-actin interacts also opens new routes of investigation
into a potential function of nuclear RACK1 in transcription elongation and the nucleo-cyto-
plasmic shuttling of mRNAs.
In summary, the present study reveals that the scaffolding protein RACK1 binds to β-actin
in a cAMP-dependent manner and that a functional interplay between RACK1 and β-actin is
key for the regulation of BDNF transcription. Therefore, our findings open a new route of
(0 min vs. 15 min) and #p<0.05 (15 min vs. 60 min), Newman-Keuls post-hoc analysis. B The table depicts the quantity of BDNF PIV in the
β-actin, IgG control or Protein G ChIP samples, expressed as percent of input ± SEM. One-way ANOVA detected a significant effect of the
treatment [P = 0.041]. *p<0.05 (0 min vs. 15 min), Newman-Keuls post-hoc analysis. C SH-SY5Y cells were infected with control
adenovirus (shCT) or adenovirus expressing shRACK1 for 3 days before treatment with 10 μM FSK for the indicated time points. A ChIP
assay was then conducted as described in A. A n = 6, B n = 4 and C n = 2 per group.
doi:10.1371/journal.pone.0160948.g006
RACK1/β-Actin and BDNF Transcription
PLOS ONE | DOI:10.1371/journal.pone.0160948 August 9, 2016 14 / 17
investigation regarding the regulation of actin filaments and nuclear actin functions through
RACK1 scaffolding properties in normal cell physiology and diseases.
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